This calculator supports UK/US assumptions only. Choose the applicable market in the calculator or its named UK/US tool. Israeli rules are not implemented.
Every grant, every vest schedule, every year. Concentration risk made explicit so the next vest decision is one informed by the whole picture, not one grant at a time.
Elevated concentration. Consider selling some vested shares and diversifying. A 30% drop in the company stock would materially affect your overall position.
After-tax estimate uses an average effective rate, not your true marginal stack. Concentration treats only unvested RSU value as company exposure; if you also hold vested company shares not yet sold, add those into the net-worth figure to capture the full picture.
Worth keeps the dashboard live against your full balance sheet and flags when your sell-at-vest policy is slipping. Join the waitlist.
Because they're already economically yours, even if not yet liquid. Your career trajectory is correlated with the company too, a bad quarter can hit comp, vest values, and job security simultaneously. The honest concentration number includes them.
A pre-committed rule to sell all (or most) RSUs as they vest, without trying to time the stock. Removes single-name concentration risk mechanically and avoids the behavioural bias of holding company stock because you 'know' it's going up. Most financial planners recommend this as the default for non-executive employees.
A rough average, your true marginal rate depends on bracket, deductions, state, NI bands, and whether you're in PAYE or estimated taxes. Treat the after-tax figure as a planning ballpark, not a tax-return number.